IL4 and B-cell chronic lymphocytic leukemia: The Th1 induction was also sustained by the observation in CLL patients treated with ibrutinib, showing a decrease level in serum of Th2-type cytokines such as IL4 and IL10 at day 28 of treatment compare to baseline.